Background--The mortality rate from cardiovascular disease (CVD) among young adults has declined less than that in the older population, raising concerns about the increasing prevalence of obesity-related conditions including hypercholesterolemia in the younger population. We investigated the age-standardized mean levels of serum cholesterols and the prevalence, awareness, treatment and control rates of hyper-low-density lipoprotein (LDL)-cholesterolemia based on age.
C ardiovascular disease (CVD) is one of the major leading causes of morbidity and mortality worldwide. 1, 2 A high level of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) is recognized as a significant contributing factor to the initiation and progression of atherosclerosis, an important risk factor for CVD. 3, 4 Numerous clinical trials have demonstrated the efficacy and safety of lipid-lowering drugs, primarily statins, in reducing CVD risk. [5] [6] [7] However, a large proportion of adults with high TC and LDL-C still remain underdiagnosed and undertreated in the United States. 4 Data from the National Health and Nutrition Examination Survey (NHANES), [2005] [2006] [2007] [2008] shows that 33.5% of adults in the United States aged ≥20 years have high LDL-C, but only 48.1% of them are treated. 8 It has been also reported that 49.1% of the United States population with TC ≥240 mg/dL are unaware of their condition. 9 Based on data from the World Health Organization Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) project, the average rate of hypercholesterolemia awareness is only 36% (ranging from 3% [0%] to 62% [65%] in men [women] ). 10 Recently, it has become clear that earlier treatment beginning at age 30 or 35 years can improve the impact of lowering blood cholesterol level on CVD risk, thanks to advances in our understanding of the mechanisms regulating blood cholesterol level and the genes involved in that regulation. 11 Therefore, early screening, diagnosis, and treatment of hypercholesterolemia are important to decrease the incidence of CVD in high-risk subjects. The prevalence of hypercholesterolemia varies considerably among population groups. 10 Variations in diet, adiposity, and the use of drugs to lower cholesterol level have led to differences in serum cholesterol concentrations across populations and over time. 3 One recent longitudinal study has clearly demonstrated that CVD mortality is not significantly decreased in young adults compared with older ones over a time period of 20 years, 12 indicating that a large number of younger adults are not sufficiently protected from CVD deaths in spite of marked developments in pharmacotherapy and intervention techniques to manage CVD. To date, no study has yet examined differences in awareness and treatment rates of hypercholesterolemia between younger and older age groups. Besides the NHANES data from the United States, there are few well-conducted national reports on awareness, treatment and control rates of hypercholesterolemia in the general population of other countries, especially in Asia. 13 Therefore, we analyzed data from the Korea National Health and Nutrition Examination Survey (KNHANES) conducted in 2008-2010, which was designed by the Ministry of Health and Welfare to regularly assess the health and nutritional status of the civilian, non-institutionalized population of Korea. Hyper-LDL-cholesterolemia was determined after calculating individual risks by the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) Guidelines. 14 The aims of this study were (1) to investigate the levels of serum cholesterols and the prevalence, awareness, treatment, and control of subjects with high LDL-C and (2) to examine differences in awareness, treatment and control rates between age groups in the general Korean population.
Methods

Study Participants
Data for this current study were derived from the KNHANES conducted in 2008-2010. The KNHANES is a nationwide cross-sectional study regularly conducted by the Division of Chronic Disease Surveillance, Korea Centers for Disease Control and Prevention of the Ministry of Health and Welfare to assess the general health and nutrition status of the civilian, non-institutionalized population of Korea. 15 The KNHANES includes 4 surveys: a health interview survey, a health behavior survey, a health examination survey, and a nutrition survey. 16 A total of 29 235 individuals participated in the KNHANES 2008-2010 ( Figure 1 ). Among these participants, we excluded individuals who were aged <20 years (n=7664) and whose lipid profiles were not assessed in the survey (n=2082 
Measurements of Anthropometric and Laboratory Parameters
Blood samples collected from each subject during the survey were processed, refrigerated immediately, transported in cold storage to the central laboratory (Neodin Medical Institute, Seoul, Korea) and analyzed within 24 hours after transportation. 17 TC, high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and fasting glucose levels were determined using a Hitachi 7600 automated chemistry analyzer (Hitachi, Tokyo, Japan). LDL-C was calculated using the Friedewald formula: [LDL-C (mg/dL)=TC (mg/dL)À{HDL-C (mg/dL)+TG (mg/dL)/5}] if the TG level was low (≤400 mg/dL) and measured directly using the Hitachi 7600 analyzer if the TG level was high (>400 mg/dL). Body mass index (BMI) was determined as the ratio of weight to height (kg/m 2 ). Standardized health questionnaires were used to determine behavior and lifestyle characteristics including cigarette smoking status (never or past/current). Blood pressure was measured 3 times on the right arm while the individual was in a seated position after at least 5 minutes of rest using a mercury sphygmomanometer (Baumanometer; W.A. Baum Co.). The final blood pressure value was obtained by averaging the second and third blood pressure readings. 
Definitions
We applied the definition of obesity in the Asian-Pacific region (BMI ≥25 kg/m 2 ) to categorize participants as obese. 18 Diabetes mellitus was defined on the basis of (1) 
Statistical Analysis
The standardized prevalence, awareness, and treatment rates were calculated for sex and age, specific to the Korean population, as provided by the Office for National Statistics in 2010 to adjust and reflect the age structure of the 2010 general population in Korea. We also applied the stratification variables and sampling weights for all analyses designated by the Korean Centers for Disease Control and Prevention, which were derived from the sample design of each survey year. 21 Sampling weights were applied to all calculations to obtain nationally representative prevalence estimates in Korea. These weights, which account for the demographic characteristics of certain areas where participants were sampled, reflect the unequal probabilities of selection of subjects, participant nonresponse, and poststratification. We stratified our analyses by age, sex, region, and family income (quartiles). Household income was calculated according to the monthly equivalized gross household income (the equivalized gross household income is the total household income divided by the root of the number of household members) and categorized into 4 quartiles as low, low middle, high middle, high. Table 2 displays the clinical features of the sample stratified by age. In both men and women, subjects aged 30 to 60 years were recruited more heavily than the other age groups in order to reflect the current age distribution in Korean society. Across all age groups, 31% (26%) men (women) were hypertensive and 11% (9%) men (women) were diabetic. More men than women were overweight/obese and reported a lifetime history of smoking. 
Results
Characteristics of the General Korean Population
Age-standardized Mean Serum Levels of Total Cholesterol and LDL-Cholesterol by Age and Gender
The age-standardized mean serum concentrations of TC, HDL-C, LDL-C, and TG were 186.8, 48.0, 112.9, and 136.0 mg/dL, respectively, in Korean adults aged ≥20 years (Table 3 ). Mean TC level was similar between men and women ≥20 years of age; however, it was significantly different across age groups ( Figure 2) . Mean serum TC level tended to increase with age up to %50 years, after which it declined gradually in men. In contrast, TC level was markedly elevated for women 45 to 55 years old, and they also maintained higher levels compared with those in men >55 years of age ( Figure 2A ). This indicates that lipid metabolism may be affected by changes in sex hormones such as estrogen in postmenopausal women. 22 Trends in LDL-C ( Figure 2B ) level by age and gender was similar with the patterns observed for TC. In men, LDL-C level increased until the 40s, after which it declined gradually. In women, LDL-C level increased until the 50s, showing abrupt elevation between 40s and 50s. This LDL-C elevation between 40s and 50s in women made the higher LDL-C level in women compared with men after 50s, while men showed higher LDL-C level than women until 40s. The mean TG level in men increased until 40s, after that it declined gradually. In contrast, the mean TG level in women increased continuously and showed a higher level than men after 70s. The HDL-C level showed decreasing tendency with increasing age both in men and women, however the differences among age groups were smaller than other lipid parameters (Table 3) . These age-and gender-related differences in serum cholesterol levels could be partly explained by the prevalence of obesity in Korea (Figure 3 ). Trends in mean TC and LDL levels between men and women were comparable to the changes in BMI, waist circumference, and proportion of subjects with obesity and overweight by ages and gender. In addition, younger men tended to have higher consumption of cigarettes and alcohol but less exercise (data not shown), which might contribute to the increase in cholesterol levels in men aged between 30s and 40s.
Age-standardized mean levels of TC, LDL-C, and TG were significantly higher in women living in rural Korea compared to those in urban areas, whereas no significant difference was observed in men based on residence (Table 3 ). In terms of economic status, men with higher incomes tended to have higher TC and LDL-C levels, and women with higher incomes had significantly lower levels of TC, LDL-C, and TG. Unexpectedly, subjects with impaired fasting glucose showed higher levels of TC and LDL-C than diabetic or normal subjects, regardless of gender. Furthermore, TC, LDL-C, and TG levels were significantly increased in both prehypertensive and hypertensive subjects compared with the normotensive population.
Prevalence and Awareness of Hyper-LDLCholesterolemia
The overall age-standardized prevalence of hyper-LDL-cholesterolemia, determined by individual risk based on the ATP III guideline was 23.2% ( Figure 4A ). Particularly, young and middle-aged adults (<50 years) showed significantly lower prevalence of hyper-LDL-cholesterolemia (3.5% to 18.9%) compared with older individuals (35.6% to 48.2%). The prevalence of subjects with high LDL-C increased with age until the 50s and reached a plateau in men, while it gradually increased over the entire age range in women ( Figure 5A ).
Among all subjects with a high LDL-C or those who reported using cholesterol-lowering medications, the overall proportion of those who were aware of their hyper-LDLcholesterolemia was 13.2% ( Figure 4B ). The awareness of high LDL-C was significantly low in young and middle-aged population (aged <50 years, 4.2% to 12%), compared with individuals aged between 50 and 69 years (24.0% to 24.6%). It gradually increased with age until 60s (from 4.2% to 24.6%), whereas significantly decreased in the elderly aged ≥70 years. In terms of gender, women were more aware of their condition than men ( Figure 5B, 14.8% versus 11.5%). The difference of awareness between genders was especially prominent in ages >40 years. Figure 6 describes the treatment and control of hyper-LDLcholesterolemia stratified by age. The overall treatment rate among subjects with high LDL-C was estimated to be 10.2% ( Figure 6A ). The distribution of treatment rates across age showed a similar pattern with that of awareness rates; young and middle-aged adults (aged 20 to 49 years) had significantly lower treatment rates, whereas older subjects (≥50 years) showed higher rates of treatment (2.4% to 8.5% versus 12.8% to 22.0%, P<0.001). The treatment rate for the subjects who were already aware of their condition was much higher (52.3%, Figure 6B ). Similarly, among individuals aware of high LDL-C, young and middle-aged adults were less likely to be treated for high cholesterol than elderly subjects (19.3% to 48.9% versus 72.9% to 92.0%, P<0.001). Of all ages, the treatment rate showed a modest increase in women compared with men except for the ages between 40 and 49 ( Figure 7A and 7B) .
Treatment and Control of Hyper-LDLCholesterolemia
Among participants who reported using cholesterol-lowering medications, the proportion of subjects who achieved LDL-C levels below their individual LDL-C goals was 61.7% ( Figure 6D ). Contrary to the findings above, young or middleaged adults (<50 years) had significantly higher LDL-C control rates compared with the older population aged ≥50 years (80% to 84.1% versus 55.6% to 74.2%, P<0.001). Particularly, younger men aged <50 years were more likely to have their LDL-C at goal when compared with women ( Figure 7D ). The overall average control rate was 7.1% among all subjects defined as high LDL-C ( Figure 6C ). 
Discussion
Under the increasing prevalence of CVD-related risk factors such as high TC or LDL-C, hypertension and obesity, 1 of every 3 deaths in the United States is attributable to CVD, and strikingly, about 20% of CVD deaths occur before the age of 65 years. Similarly, mortality rates from ischemic heart disease in Korea have increased >3 times during 15 years. After statins were first introduced as a lipid-lowering drug in the 1980s, the Cholesterol Treatment Trialists' Collaborators reported an %20% relative risk reduction with statins for major vascular events per 38.6 mg/dL (1 mmol/L) decrease in LDL-C, 24 demonstrating the preponderance of evidence of the benefit of statins on CVD. Although there have been significant advances in the research of the epidemiology of and preventive medicine for CVD, the burden of public disease still remains high and may be increasing in the future 25 as the rate of obesity increases, populations age, and physical activity levels decrease. In the era of statins and the obesity epidemic, we investigated the prevalence, awareness, treatment, and control of adults with high cholesterol based on age using a national public health survey dataset in Korea. To date, not many studies have investigated the prevalence, awareness, treatment, and control rates of high blood cholesterol level in the general population of Asia. 13 Our study population is representative of the general Korean population as a whole because the KNHANES is an official, nationwide database that reflects the geographic and demographic differences found in Korea. In general, for Korean adults ≥20 years of age, the age-standardized mean values of TC, may be due to an increase in the prevalence of metabolic syndrome in Korea. 26 Mean levels of LDL-C and TG in Korean adults were higher when compared with a national dataset of Chinese adults from 2001, whereas HDL-C was lower (TC, HDL-C, LDL-C, TG; 186, 51.7, 109.5, 128.1 mg/dL, respectively). 13 Although mean TC, HDL-C, and LDL-C values were Despite the small number of studies regarding the prevalence of hypercholesterolemia in the general populations of Asian countries, the prevalence of hyper-LDL-cholesterolemia in Korea was quite similar to that of China, 23.2% in our survey and 24.8% (LDL-C ≥130 mg/dL) in China. 13 However, the Chinese study did not assess LDL-C levels by individual risk status, which may overestimate the prevalence of hyper-LDL-cholesterolemia. In the United States, 28 the prevalence of LDL-C ≥130 mg/dL is 35%, which is significantly higher than in Asian countries. Our study has several distinguishable features. First, in younger adults (<50 years), men had significantly higher levels of TC and LDL-C, while women showed markedly elevated values of TC and LDL-C compared with men when they became older than 50 years. These findings are likely to be associated with the age and gender difference in obesity prevalence in Korea, suggesting that intensive modification in lifestyles to control body weight should be necessary especially for younger men (<50 years) and older women (≥50 years). Second, pharmacotherapy for high LDL-C was more effective in the young and middle-aged population (30 to 49 years, 82.1%) than in elderly subjects (≥60 years, 61.6%) with average control rates of 61.7%. This figure is lower 30 Hypercholesterolemia control rates vary depending on the population and country, with rates ranging from 18% to 100%. 10 Third, the overall treatment rate for subjects with high LDL-C was 10.2% in Korea. This rate is markedly lower when we compare the treatment rate from a United States population that reported a rate of 48% 8 as well as rates of other chronic diseases in Korea; the treatment rates for hypertension 31 and diabetes 32 were 66% and 49%, respectively. However, the treatment rate for subjects who were aware of their high LDL-C was noticeably increased to 52.3%. Considering the impact of hypercholesterolemia on the development of CVD, vigorous efforts are necessary within the public health field to provide proper education and counsel about the screening and management of hypercholesterolemia to laypersons. Lastly, awareness and treatment rates of high LDL-C were significantly lower in younger adults <50 years old (awareness, 8.0%; treatment, 5.1%) compared with those who were ≥50 years old (21.5%; 18.5%), although the prevalence of high LDL-C was not high in young or middle-aged adults. This suggests that there is a large proportion of undiagnosed subjects who are at high risk for CVD among young or middleaged individuals. Based on our findings, we can assume that, out of 100 subjects with hyper-LDL-cholesterolemia aged <50 years, 8 are aware of their condition, 5 are being treated with cholesterol-lowering agents, and 3 subjects have their LDL-C levels under control, implying that 97% of young and middle-aged individuals will remain as potentially high-risk subjects for CVD. 16 Consistent with our results, the study from the NHANES 2005-2008 reported that the treatment rate for high LDL-C was 11% in adults aged 20 to 39 years but 48% and 64% in adults aged 40 to 64 years or ≥65 years, respectively. 8 Recent data demonstrates that trends in mortality rates from CVD among young adults have declined less rapidly than the rates in the older population over the past 20 years, 12 raising concerns about young adults with a high risk for CVD death. This unfavorable finding is a result of an increasing prevalence of obesity-related conditions such as metabolic syndrome, 33 hypertension, 34 and hypercholesterolemia 5 in the young and middle-aged population. Although NCEP ATP III guidelines define men who are ≥45 years old and women who are at least ≥55 years old as high risk for CVD, 14 our data clearly suggest that more attention should be paid to younger subjects who may be undiagnosed for hypercholesterolemia in order to alleviate the increasing trend of CVD among young adults. The present study has some potential limitations that should be addressed in future investigations. First, as these findings were derived from a cross-sectional study, it is difficult to conclude that lower rates of awareness and treatment in young and middle-aged adults can directly lead to an increase in the incidence of future CVD events. Subsequent prospective studies are needed to validate this hypothesis and support our findings. Second, we could not perform additional analyses to identify putative reasons for why the younger age groups had a lower awareness of their cholesterol condition due to the lack of related information in the dataset.
The present results demonstrate that significant proportions of young and middle-aged adults are unaware of their hyper-LDL-cholesterolemia and are not treated with proper lipid-lowering medications. Considering the impact of CVD on an individual's quality of life and the public health burden of the disease, intensive efforts in national public healthcare policy regarding early screening and education is indispensable to decrease potentially high-risk individuals for CVD. Further research is warranted to confirm the impact of low awareness and treatment rates in young adults on development of CVD and to establish effective screening tools for identifying individuals with hyper-LDL-cholesterolemia.
